Helicobacter pylori infection in hemodialysis patients: Susceptibility to amoxicillin and clarithromycin

doi:10.3748/wjg.v11.i6.842

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3028)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-2) series.

Item

Count

PDF

295

HTML

2529

Tables (1-2)

204

Sum=3028

Feb 14, 2005 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Feb 14, 2005; 11(6): 842-845
Published online Feb 14, 2005. doi: 10.3748/wjg.v11.i6.842

Helicobacter pylori infection in hemodialysis patients: Susceptibility to amoxicillin and clarithromycin

Selim Aydemir, Sedat Boyacioglu, Gurden Gur, Muge Demirbilek, Fusun Kamber Can, Murat Korkmaz, Ugur Yilmaz

Selim Aydemir, Department of Gastroenterology, Zonguldak Karaelmas University Faculty of Medicine, 67800, Zonguldak, Turkey

Sedat Boyacioglu, Gurden Gur, Murat Korkmaz, Ugur Yilmaz, Department of Gastroenterology, Baskent University Faculty of Medicine, 06000, Ankara, Turkey

Muge Demirbilek, Fusun Kamber Can, Department of Clinical Microbiology, Baskent University Faculty of Medicine, 06000, Ankara, Turkey

Author contributions: All authors contributed equally to the work.

Correspondence to: Dr. Selim Aydemir, Department of Gastroenterology, Zonguldak Karaelmas University Faculty of Medicine, 67800, Zonguldak, Turkey. selimaydemir@hotmail.com

Telephone: +90-372-2576169

Received: July 5, 2004
Revised: July 7, 2004
Accepted: October 13, 2004
Published online: February 14, 2005

Abstract

AIM: To evaluate susceptibility of Helicobacter pylori to amoxicillin and clarithromycin in end-stage renal disease (ESRD) patients and non-uremic controls.

METHODS: The subjects with dyspeptic complaints were 33 ESRD patients and 46 age- and sex-matched non-uremic controls who exhibited H pylori on antral biopsy specimens. The two groups were age and sex matched. The H pylori strains’ pattern of susceptibility to amoxicillin and clarithromycin was investigated with the agar dilution technique.

RESULTS: None of the H pylori strains from either group showed resistance to amoxicillin with the agar dilution method. Twelve (36.4%) of the ESRD group strains and 7 (15.2%) of the control group strains showed resistance to clarithromycin, and this difference was statistically significant (P<0.05).

CONCLUSION: Resistance to amoxicillin does not appear to be an important problem in H pylori-infected ESRD and non-uremic patients in our region. In contrast, the rates of resistance to clarithromycin are high, particularly in the ESRD population.

Keywords: Helicobacter pylori; Chronic renal failure; Antibiotic resistance; Clarithromycin; Amoxicillin